Winter D C, Walsh R, Lee G, Kiely D, O'Riordain M G, O'Sullivan G C
Department of Surgical Oncology, Cork Cancer Research Centre, Mercy University Hospital, Grenville Place, Cork, Ireland.
Ann Surg Oncol. 2007 Jan;14(1):69-73. doi: 10.1245/s10434-006-9031-y. Epub 2006 Oct 25.
Colorectal cancers that adhere to the urinary bladder require en-bloc partial or total cystectomy to achieve negative tumor margins.
This prospective study evaluated the outcome of combined bladder resection for carcinoma of the colon or rectum at a unit specializing in gastrointestinal cancer.
Patients (n = 63) with colorectal tumors adherent to the bladder at operation and without distal metastases were followed. Fifty-eight patients (92%) had tumors of the sigmoid colon or upper rectum. Operative morbidity and mortality rates were 18% and 1.5%, respectively. Histological staging demonstrated bladder adherence in 46% (29/63) and invasion in 54% (34/63). Overall disease-specific survival was 54% with a mean follow-up of 7.6 years (range 5-12). Five-year survival for margin-negative patients was 72% (26/36) and 27% (4/15) for node-negative and -positive tumors, respectively. The bladder was closed primarily in 48 patients and reconstructed by enterocystoplasty in 5, with 10 patients requiring urinary diversion.
En-bloc bladder resection for adherent or invading tumors of the colon and rectum achieves good local control, but an infiltrative extravesical margin denotes poor prognosis. The potential for cure in completely excised node-negative tumors is good. Bladder reconstruction is achievable in most patients.
侵犯膀胱的结直肠癌需要整块切除部分或全部膀胱以实现肿瘤切缘阴性。
这项前瞻性研究评估了一家专门治疗胃肠道癌症的机构中,联合膀胱切除术治疗结肠癌或直肠癌的疗效。
对术中发现结直肠肿瘤侵犯膀胱且无远处转移的患者(n = 63)进行了随访。58例(92%)患者的肿瘤位于乙状结肠或直肠上段。手术并发症发生率和死亡率分别为18%和1.5%。组织学分期显示,46%(29/63)的患者存在膀胱粘连,54%(34/63)的患者存在膀胱侵犯。总体疾病特异性生存率为54%,平均随访7.6年(范围5 - 12年)。切缘阴性患者的5年生存率为72%(26/36),淋巴结阴性和阳性肿瘤患者的5年生存率分别为27%(4/15)。48例患者膀胱一期缝合,5例患者行肠膀胱扩大术重建膀胱,10例患者需要尿流改道。
整块切除侵犯膀胱的结直肠肿瘤可实现良好的局部控制,但膀胱外浸润切缘提示预后不良。完全切除的淋巴结阴性肿瘤有治愈的可能。大多数患者可以实现膀胱重建。